Australia: Client Success
Last Updated: 30 November 2007

Nanosonics Limited (Nanosonics) specialises in the area of innovative infection control technologies. Infection control is the practice of preventing the transmission of pathogenic micro-organisms to patients or healthcare workers. It is becoming increasingly important for a variety of reasons such as an increased level of microbial resistance to many existing disinfection methods, an increased awareness of pandemics such as Avian Flu and SARS and a trend away from disposable instrumentation.

Nanosonics’ core technology involves the use of an aerosol of highly concentrated droplets of hydrogen peroxide which are smaller than any bacteria (NanoNebulant™). The NanoNebulant™ distributes evenly and quickly in an area, much like a gas, but still retains the properties of a liquid. The NanoNebulant™ can be applied to a variety of public spaces and instruments requiring decontamination, from small chambers to large rooms. The process operates in a closed system, and the devices have a built-in system which completely breaks down residual peroxide at the end of the process, yielding small quantities of water and oxygen.

Compared to existing methods, Nanosonics technology is rapid, safe to operate and has been shown to be highly effective against a broad range of pathogens. It has been validated against a range of international regulatory standards. Over the course of several years, Shelston IP has assisted Nanosonics in the development of a strategically designed suite of patent applications covering this technology.

Nanosonics recently listed on the Australian Securities Exchange (ASX:NAN). The share offer was a major success, being heavily oversubscribed and raising $27M to further develop Nanosonics’ range of medical disinfection products. Nanosonics has also received significant grants from Ausindustry.

For more information on Nanosonics, visit

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By Gareth Dixon
By Tracey Murray, Claire McDowall, David Mason
By Jack Redfern
By Nathan Sinclair, Sean McManis
By Sean McManis
By Gareth Dixon
By Grant Shoebridge
By Matthew Ward
By Peter Treloar
By Serena White DPhil, Jacinta Flattery-O'Brien
Font Size: